These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 24329981)
1. Endogenous sex hormones and risk of venous thromboembolism in women and men. Holmegard HN; Nordestgaard BG; Schnohr P; Tybjaerg-Hansen A; Benn M J Thromb Haemost; 2014; 12(3):297-305. PubMed ID: 24329981 [TBL] [Abstract][Full Text] [Related]
2. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study. Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701 [TBL] [Abstract][Full Text] [Related]
3. The genetic effects of hormones modulated by the Pituitary-Thyroid/Adrenal/Gonadal axis on the risk of developing venous thromboembolism: a mendelian randomization study. Tian H; Xie C; Teng B; Zeng Q; Zhao Y; Li F; Jiang C; Chen Z BMC Cardiovasc Disord; 2024 Jul; 24(1):383. PubMed ID: 39054435 [TBL] [Abstract][Full Text] [Related]
4. Endogenous sex hormones and risk of venous thromboembolism in young women. Scheres LJJ; van Hylckama Vlieg A; Ballieux BEPB; Fauser BCJM; Rosendaal FR; Middeldorp S; Cannegieter SC; J Thromb Haemost; 2019 Aug; 17(8):1297-1304. PubMed ID: 31054196 [TBL] [Abstract][Full Text] [Related]
5. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Benn M; Voss SS; Holmegard HN; Jensen GB; Tybjærg-Hansen A; Nordestgaard BG Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):471-7. PubMed ID: 25550203 [TBL] [Abstract][Full Text] [Related]
6. Prospective Study of Endogenous Hormones and Incidence of Venous Thromboembolism: The Atherosclerosis Risk in Communities Study. Roetker NS; MacLehose RF; Hoogeveen RC; Ballantyne CM; Basu S; Cushman M; Folsom AR Thromb Haemost; 2018 Nov; 118(11):1940-1950. PubMed ID: 30296818 [TBL] [Abstract][Full Text] [Related]
7. Sex-Specific Risk Factors for Deep Venous Thrombosis and Pulmonary Embolism in a Population-Based Historical Cohort Study of Middle-Aged and Older Individuals. Brink A; Elf J; Svensson PJ; Engström G; Melander O; Zöller B J Am Heart Assoc; 2023 Mar; 12(5):e027502. PubMed ID: 36847045 [TBL] [Abstract][Full Text] [Related]
8. Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Severinsen MT; Johnsen SP; Tjønneland A; Overvad K; Dethlefsen C; Kristensen SR Eur J Intern Med; 2010 Aug; 21(4):268-72. PubMed ID: 20603033 [TBL] [Abstract][Full Text] [Related]
9. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419 [TBL] [Abstract][Full Text] [Related]
10. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study. Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714 [TBL] [Abstract][Full Text] [Related]
11. Sex-specific differences in the presenting location of a first venous thromboembolism. Scheres LJJ; Brekelmans MPA; Beenen LFM; Büller HR; Cannegieter SC; Middeldorp S J Thromb Haemost; 2017 Jul; 15(7):1344-1350. PubMed ID: 28440013 [TBL] [Abstract][Full Text] [Related]
12. Testosterone, thrombophilia, thrombosis. Freedman J; Glueck CJ; Prince M; Riaz R; Wang P Transl Res; 2015 May; 165(5):537-48. PubMed ID: 25639953 [TBL] [Abstract][Full Text] [Related]
13. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism. Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184 [TBL] [Abstract][Full Text] [Related]
15. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study. Svartberg J; Braekkan SK; Laughlin GA; Hansen JB Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774 [TBL] [Abstract][Full Text] [Related]
16. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study. Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625 [TBL] [Abstract][Full Text] [Related]
17. Observationally and Genetically High YKL-40 and Risk of Venous Thromboembolism in the General Population: Cohort and Mendelian Randomization Studies. Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1030-6. PubMed ID: 26988593 [TBL] [Abstract][Full Text] [Related]
18. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies. Galanaud JP; Bosson JL; Genty C; Presles E; Cucherat M; Sevestre MA; Quere I; Decousus H; Leizorovicz A J Thromb Haemost; 2012 Jun; 10(6):1004-11. PubMed ID: 22429908 [TBL] [Abstract][Full Text] [Related]
19. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS). Isma N; Svensson PJ; Gottsäter A; Lindblad B Thromb Res; 2009 Dec; 124(6):663-6. PubMed ID: 19497611 [TBL] [Abstract][Full Text] [Related]
20. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review. Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]